Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A joint trial of the Australasian Leukaemia and Lymphoma Group (ALLG) and the French CLL branch of the French Innovative Leukemia Organization (FILO) evaluating role of Lenalidomide consolidation in patients with Chronic Lymphocytic Leukemia following initial fludarabine, cyclophosphamide and rituximab (FCR) Chemotherapy

Next Previous
X
Search
Trial Profile

A joint trial of the Australasian Leukaemia and Lymphoma Group (ALLG) and the French CLL branch of the French Innovative Leukemia Organization (FILO) evaluating role of Lenalidomide consolidation in patients with Chronic Lymphocytic Leukemia following initial fludarabine, cyclophosphamide and rituximab (FCR) Chemotherapy

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lenalidomide (Primary)
  • Indications Chronic lymphocytic leukaemia
  • Focus Therapeutic Use
  • Acronyms CLL6 RESIDUUM

    • Most Recent Events

    • 12 Dec 2023 Status changed from active, no longer recruiting to discontinued because of an acute lymphoblastic leukemia (ALL) warning (3 of 56 patients [5.4%]) in the CLLM1 trial .
    • 12 Dec 2023 Results presented at the 65th American Society of Hematology Annual Meeting and Exposition
    • 15 Jun 2023 Results from an ancillary study assessing the health-related quality of life from French patients in this study, presented at the 28th Congress of the European Haematology Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top